Jun Lu
Corporate Officer/Principal bei SHANDONG BOAN BIOTECHNOLOGY CO., LTD.
Aktive Positionen von Jun Lu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Corporate Officer/Principal | 09.03.2015 | - |
Karriereverlauf von Jun Lu
Ehemalige bekannte Positionen von Jun Lu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2013 | 01.03.2015 |
Ipsen Bioscience, Inc.
 Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA. | Corporate Officer/Principal | 01.07.2006 | 01.03.2013 |
Ausbildung von Jun Lu
| Peking University | Undergraduate Degree |
| University of Southern California | Graduate Degree |
| The University of Chicago | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| China | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ipsen Bioscience, Inc.
Ipsen Bioscience, Inc. BiotechnologyHealth Technology Part of Ipsen SA, Ipsen Bioscience, Inc. is a company that develops and wholesales drugs. The company is based in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |